Anthony G Wilson
Overview
Explore the profile of Anthony G Wilson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
4376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ling S, Ogungbenro K, Darwich A, Ariff A, Nair N, Bluett J, et al.
Pharmaceutics
. 2024 Jun;
16(6).
PMID: 38931826
Efficacy to biologics in rheumatoid arthritis (RA) patients is variable and is likely influenced by each patient's circulating drug levels. Using modelling and simulation, the aim of this study was...
2.
Charles-Schoeman C, Giles J, Lane N, Choy E, Furst D, Vencovsky J, et al.
Rheumatol Ther
. 2024 Jan;
11(1):157-175.
PMID: 38180720
Introduction: Upadacitinib (UPA) is a Janus kinase inhibitor that has demonstrated efficacy in moderate-to-severe rheumatoid arthritis (RA) with an acceptable safety profile. We investigated laboratory parameter changes in UPA RA...
3.
Yap C, Nair N, de Vries A, Loeff F, Morgan A, Isaacs J, et al.
Ann Rheum Dis
. 2023 Sep;
83(2):263-265.
PMID: 37699653
No abstract available.
4.
Ling S, Yap C, Nair N, Bluett J, Morgan A, Isaacs J, et al.
Rheumatology (Oxford)
. 2023 Jun;
63(4):1015-1021.
PMID: 37389432
Objectives: Biologic DMARDs (bDMARDs) are widely used in patients with RA, but response to bDMARDs is heterogeneous. The objective of this work was to identify pretreatment proteomic biomarkers associated with...
5.
OLeary D, Al Julandani D, Zia M, Klotsche J, Minden K, Roderick M, et al.
Pediatr Rheumatol Online J
. 2023 Jun;
21(1):52.
PMID: 37277844
Objectives: To determine the influence of HLA-B27 positivity on risk of developing chronic nonbacterial osteomyelitis (CNO). Methods: HLA-B*27 genotype was assessed in 3 European CNO populations and compared with local...
6.
Nair N, Wilson A
Expert Rev Clin Immunol
. 2023 Mar;
19(5):483-488.
PMID: 36974634
Introduction: Although there are gold-standard diagnostic guidelines and effective treatments to slow the disease progression of rheumatoid arthritis (RA), approximately 40% of patients still do not respond adequately to their...
7.
Smith S, Alexander S, Nair N, Viatte S, Eyre S, Hyrich K, et al.
Ann Rheum Dis
. 2023 Feb;
82(5):611-620.
PMID: 36810200
Objectives: The inflammatory protein calprotectin (MRP8/14) has been identified as a promising biomarker of treatment response in rheumatoid arthritis (RA). Our aim was to test MRP8/14 as a biomarker of...
8.
Hum R, Ho P, Nair N, Jani M, Morgan A, Isaacs J, et al.
Rheumatology (Oxford)
. 2022 Oct;
62(6):2090-2097.
PMID: 36190343
Objectives: Interventions aimed at increasing TNF-α inhibitor serum drug levels (SDLs) may improve treatment response; however, previous studies suggesting SDL cut-offs have not accounted for treatment adherence. The aim of...
9.
Alexander Jr L, Huebner J, Cicconetti G, Jordan J, Renner J, Doherty M, et al.
Osteoarthr Cartil Open
. 2022 Sep;
4(3).
PMID: 36081777
Objective: To evaluate the degree of symmetry of knee osteoarthritis (OA) structural severity and progression of participants with a mean follow-up time of 3.8 years. Design: Participants from the Genetics...
10.
Sutcliffe M, Nair N, Oliver J, Morgan A, Isaacs J, Wilson A, et al.
Rheumatology (Oxford)
. 2022 Apr;
61(12):4935-4944.
PMID: 35377444
Background: No reliable biomarkers to predict response to TNF inhibitors (TNFi) in RA patients currently exist. The aims of this study were to replicate changes in gene co-expression modules that...